NO941185L - Anvendelse av bisfosfonsyrederivater for fremstilling av legemidler for påskynding av benreparasjon - Google Patents

Anvendelse av bisfosfonsyrederivater for fremstilling av legemidler for påskynding av benreparasjon

Info

Publication number
NO941185L
NO941185L NO941185A NO941185A NO941185L NO 941185 L NO941185 L NO 941185L NO 941185 A NO941185 A NO 941185A NO 941185 A NO941185 A NO 941185A NO 941185 L NO941185 L NO 941185L
Authority
NO
Norway
Prior art keywords
amino
acid derivatives
bisphosphonic acid
bone repair
drugs
Prior art date
Application number
NO941185A
Other languages
English (en)
Other versions
NO941185D0 (no
NO305304B1 (no
Inventor
Alain Barbier
Frederic Lacheretz
Original Assignee
Sanofi Elf
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9445758&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO941185(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Sanofi Elf filed Critical Sanofi Elf
Publication of NO941185D0 publication Critical patent/NO941185D0/no
Publication of NO941185L publication Critical patent/NO941185L/no
Publication of NO305304B1 publication Critical patent/NO305304B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Materials For Medical Uses (AREA)
NO941185A 1993-04-05 1994-03-30 Anvendelse av bisfosfonsyrederivater for fremstilling av legemidler for pÕskynding av benreparasjon NO305304B1 (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9303999A FR2703590B1 (fr) 1993-04-05 1993-04-05 Utilisation de derives d'acide bisphosphonique pour la preparation de medicaments destines a favoriser la reparation osseuse .

Publications (3)

Publication Number Publication Date
NO941185D0 NO941185D0 (no) 1994-03-30
NO941185L true NO941185L (no) 1994-10-06
NO305304B1 NO305304B1 (no) 1999-05-10

Family

ID=9445758

Family Applications (1)

Application Number Title Priority Date Filing Date
NO941185A NO305304B1 (no) 1993-04-05 1994-03-30 Anvendelse av bisfosfonsyrederivater for fremstilling av legemidler for pÕskynding av benreparasjon

Country Status (17)

Country Link
US (1) US5488041A (no)
EP (1) EP0623347B1 (no)
JP (1) JP3062001B2 (no)
CN (1) CN1062735C (no)
AT (1) ATE207752T1 (no)
AU (1) AU680229B2 (no)
CA (1) CA2120538C (no)
DE (1) DE69428827T2 (no)
DK (1) DK0623347T3 (no)
ES (1) ES2166771T3 (no)
FR (1) FR2703590B1 (no)
HU (1) HU220764B1 (no)
IL (1) IL109212A (no)
NO (1) NO305304B1 (no)
NZ (1) NZ260244A (no)
PT (1) PT623347E (no)
ZA (1) ZA942358B (no)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995031203A1 (en) * 1994-05-17 1995-11-23 Merck & Co., Inc. Oral liquid alendronate formulations

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6406714B1 (en) 1992-12-02 2002-06-18 Merck & Co., Inc. Dry mix formulation for bisphosphonic acids
US5591730A (en) * 1993-10-12 1997-01-07 The Regents Of The University Of California Inhibition of urinary calculi growth
US20010007863A1 (en) 1998-06-18 2001-07-12 Merck & Co., Inc. Wet granulation formulation for bisphosphonic acids
TW390813B (en) * 1994-04-29 2000-05-21 Merck & Co Inc Wet granulation formulation for bisphosphonic acids
WO1996039107A1 (en) * 1995-06-06 1996-12-12 Merck & Co., Inc. Bisphosphonate cement composition to prevent aseptic loosening of orthopedic implant devices
EP0753523A1 (en) * 1995-07-10 1997-01-15 Gador S.A. Amino-substituted bisphosphonic acids
US5853759A (en) * 1996-05-17 1998-12-29 Merck & Co.. Inc. Effervescent alendronate formulation
SK42999A3 (en) * 1996-10-04 2000-01-18 Merck & Co Inc Aqueous liquid pharmaceutical formulation, process for the preparation and use thereof
US20010031244A1 (en) * 1997-06-13 2001-10-18 Chiesi Farmaceutici S.P.A. Pharmaceutical aerosol composition
US6432932B1 (en) 1997-07-22 2002-08-13 Merck & Co., Inc. Method for inhibiting bone resorption
US6015801A (en) * 1997-07-22 2000-01-18 Merck & Co., Inc. Method for inhibiting bone resorption
US5994329A (en) 1997-07-22 1999-11-30 Merck & Co., Inc. Method for inhibiting bone resorption
US8586781B2 (en) * 1998-04-02 2013-11-19 Mbc Pharma, Inc. Bone targeted therapeutics and methods of making and using the same
US6896871B2 (en) 1998-04-02 2005-05-24 Mbc Research, Inc. Biphosphonate conjugates and methods of making and using the same
US6750340B2 (en) 1998-04-02 2004-06-15 Mbc Research, Inc. Bisphosphonate conjugates and methods of making and using the same
US7598246B2 (en) * 1998-04-02 2009-10-06 Mbc Pharma, Inc. Bisphosphonate conjugates and methods of making and using the same
GB2336311A (en) * 1998-04-15 1999-10-20 Merck & Co Inc Bisphosphonate Dosing Regimen
FR2784031B1 (fr) * 1998-10-02 2002-02-01 Sanofi Elf Utilisation de derives de l'acide bisphosphonique pour la preparation d'un medicament destine au traitement des boiteries
FR2803520B1 (fr) * 2000-01-12 2002-09-20 Ceva Sante Animale Procede pour augmenter la production d'oeufs et consolider la coquille des oeufs chez les volailles
EP1136069A1 (en) * 2000-03-21 2001-09-26 SPA SOCIETA' PRODOTTI ANTIBIOTICI S.p.A. Pharmaceutical compositions containing clodronates for high local tolerance intramuscular administration
CA2372450A1 (en) * 2001-05-10 2001-09-19 Pharmaceutical Partners Of Canada Inc. Liquid injectable formulation of disodium pamidronate
EP1455796A1 (en) * 2001-12-21 2004-09-15 The Procter & Gamble Company Method for the treatment of bone disorders
US7488496B2 (en) * 2002-03-06 2009-02-10 Christer Rosen Effervescent compositions comprising bisphosphonates and methods related thereto
AU2003226148A1 (en) * 2002-04-05 2003-10-27 Merck & Co., Inc. Method for inhibiting bone resorption with an alendronate and vitamin d formulation
ES2294277T3 (es) * 2002-05-10 2008-04-01 F. Hoffmann-La Roche Ag Acidos bisfosfonicos para el tratamiento y prevencion de osteoporosis.
US20040137058A1 (en) * 2002-07-09 2004-07-15 Katdare Ashok V. Effervescent bisphosphonate formulation
US20040138180A1 (en) * 2002-10-03 2004-07-15 Barr Laboratories, Inc. Bisphosphonate composition and process for the preparation thereof
CN1649598B (zh) * 2002-12-20 2011-12-07 弗·哈夫曼-拉罗切有限公司 高剂量伊班膦酸制剂
ITMI20040218A1 (it) * 2004-02-10 2004-05-10 Abiogen Pharma Spa Uso di neridronato sodico per promuovere la neoformazione ossea
US20050261250A1 (en) * 2004-05-19 2005-11-24 Merck & Co., Inc., Compositions and methods for inhibiting bone resorption
KR100564628B1 (ko) * 2004-06-16 2006-03-28 삼성전자주식회사 스플릿 게이트형 플래쉬 메모리 소자 및 그 제조방법
WO2006018033A1 (en) * 2004-08-20 2006-02-23 Mepha Ag Formulations of bisphosphonates
US8071574B2 (en) * 2005-02-22 2011-12-06 John Dennis Bobyn Implant improving local bone formation
US20070087052A1 (en) * 2005-10-19 2007-04-19 Katdare Ashok V Effervescent bisphosphonate formulation
EP1923049A1 (en) * 2006-11-17 2008-05-21 Besins Healthcare Pharmaceutical compositions comprising a bisphosphonate compound
FR2954320B1 (fr) 2009-12-17 2012-06-15 Cll Pharma Composition pharmaceutique orale suprabiodisponible contenant un acide biphosphonique ou un de ses sels
US8882740B2 (en) * 2009-12-23 2014-11-11 Stryker Trauma Gmbh Method of delivering a biphosphonate and/or strontium ranelate below the surface of a bone
CA2843885C (en) 2011-08-01 2020-03-10 Mbc Pharma, Inc. Vitamin b6 derivatives of nucleotides, acyclonucleotides and acyclonucleoside phosphonates

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1194748B (it) * 1981-02-12 1988-09-28 Gentili Ist Spa Composizioni farmaceutiche per il trattamento di osteopatie
FR2531088B1 (fr) * 1982-07-29 1987-08-28 Sanofi Sa Produits anti-inflammatoires derives de l'acide methylenediphosphonique et leur procede de preparation
GB8419489D0 (en) * 1984-07-31 1984-09-05 Leo Pharm Prod Ltd Chemical compounds
IL77243A (en) * 1984-12-21 1996-11-14 Procter & Gamble Pharmaceutical compositions containing geminal diphosphonic acid compounds and certain such novel compounds
GB8530603D0 (en) * 1985-12-12 1986-01-22 Leo Pharm Prod Ltd Chemical compounds
CA1339805C (en) * 1988-01-20 1998-04-07 Yasuo Isomura (cycloalkylamino)methylenebis(phosphonic acid) and medicines containing the same as an active
FR2629716B1 (fr) * 1988-04-07 1991-07-19 Sanofi Sa Composition pharmaceutique pour administration orale a base d'un derive d'acide diphosphonique
US4922007A (en) * 1989-06-09 1990-05-01 Merck & Co., Inc. Process for preparing 4-amino-1-hydroxybutylidene-1,1-bisphosphonic acid or salts thereof
US5270365A (en) * 1991-12-17 1993-12-14 Merck & Co., Inc. Prevention and treatment of periodontal disease with alendronate
EP0600834A1 (en) * 1992-11-30 1994-06-08 Ciba-Geigy Ag Use of methanebisphosphonic acid derivatives for the manufacture of a medicament for fracture healing
US5403829A (en) * 1993-03-24 1995-04-04 Leiras Oy Use of bisphosphonates in endo-osteal bone surgery

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995031203A1 (en) * 1994-05-17 1995-11-23 Merck & Co., Inc. Oral liquid alendronate formulations

Also Published As

Publication number Publication date
HUT68310A (en) 1995-06-28
DK0623347T3 (da) 2002-02-11
ZA942358B (en) 1995-10-05
ES2166771T3 (es) 2002-05-01
HU220764B1 (hu) 2002-05-28
NZ260244A (en) 1997-06-24
AU5910294A (en) 1994-10-06
EP0623347A1 (fr) 1994-11-09
IL109212A (en) 2001-07-24
JPH0748261A (ja) 1995-02-21
US5488041A (en) 1996-01-30
DE69428827T2 (de) 2002-07-18
NO941185D0 (no) 1994-03-30
IL109212A0 (en) 1994-07-31
AU680229B2 (en) 1997-07-24
FR2703590A1 (fr) 1994-10-14
HU9400967D0 (en) 1994-06-28
CN1104091A (zh) 1995-06-28
CA2120538C (en) 1999-02-23
DE69428827D1 (de) 2001-12-06
CA2120538A1 (en) 1994-10-06
EP0623347B1 (fr) 2001-10-31
FR2703590B1 (fr) 1995-06-30
JP3062001B2 (ja) 2000-07-10
NO305304B1 (no) 1999-05-10
PT623347E (pt) 2002-03-28
ATE207752T1 (de) 2001-11-15
CN1062735C (zh) 2001-03-07

Similar Documents

Publication Publication Date Title
NO941185L (no) Anvendelse av bisfosfonsyrederivater for fremstilling av legemidler for påskynding av benreparasjon
IL104109A0 (en) Pharmaceutical compositions containing aldenorate for treating periodontal diseases
NO158539C (no) Analogifremgangsmaate for fremstilling av en terapeutisk aktiv 2,6-diaminopurinforbindelse.
IL120584A (en) 1,2-diphenylpyrrole derivatives, use thereof for the manufacture of a medicament and pharmaceutical compositions containing the same
IL98502A0 (en) Aminoalkane phosphinic acid derivatives,process for their preparation and pharmaceutical compositions containing them
FI885623A (fi) Menetelmä lääkeaineina käyttökelpoisten substituoitujen propaani-fosfiinihappoyhdisteiden valmistamiseksi
HUT56105A (en) Process for producing carbapenem derivatives and pharmaceutical compositions comprising same
DK330685D0 (da) Kombinationspraeparat og dets anvendelse
KR890011592A (ko) 기관내 허혈병의 치료용 조성물
IL87765A0 (en) L-dopa derivatives and their acid addition salts,process for producing same and pharmaceutical compositions containing them
CA2136553A1 (en) 7-(2-aminoethyl)-Benzothiazolones
ATE157252T1 (de) 3'-azido-2',3'-dideoxy-5-methylcytidin enthaltende antivirale zusammensetzungen
HU9201033D0 (en) Tiazolidinone- and oxazolidinone derivatives, process for their production, and for the production of medical preparations containing them as active agents
HUP0202379A2 (hu) Új vegyületek, eljárás előállításukra és a vegyületeket tartalmazó gyógyszerkészítmények
NO852514L (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 8-alkyltio-2-piperazino-pyrimido (5,4-d) pyrimidin-derivater.
HUT36812A (en) Process for preparing benzothiazine derivatives and pharmaceutical compositions containing such compounds
DE69929218D1 (de) Verwendung von bisphosphonsaüre derivaten zur herstellung eines arzneimittels zur behandlung von lahmen
DE69413333D1 (de) Benzospiroalken-Derivate, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Zusammensetzungen
HUT43586A (en) Process for production of derivatives and salts of 8-tiotetrahydro-quinoline and medical preparatives containing thereof as active substance
AU2994589A (en) Novel basic-substituted 5-halo-thienoisothiazol-3-(2h)-one-1,1-dioxides, process for the preparation thereof, and pharmaceutical preparations containing these compounds
ATE101119T1 (de) Butensaeure-amide, deren salze, diese enthaltende pharmazeutische zusammensetzungen und verfahren zu deren herstellung.
ATE90204T1 (de) Verwendung von para-aminobenzoesaeure zur herstellung eines arzneimittels zur bekaempfung von photoallergien.
PL304334A1 (en) Pharmaceutical composition of gastric protective action, including antiulceric one and method of treating diseases of gastrointestinal tract

Legal Events

Date Code Title Description
MK1K Patent expired